Intended for healthcare professionals

News

Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant

BMJ 2021; 372 doi: https://doi.org/10.1136/bmj.n296 (Published 01 February 2021) Cite this as: BMJ 2021;372:n296

Read our latest coverage of the coronavirus outbreak